EX-99.1 2 pressrelease.htm PRESS RELEASE DATED APRIL 2, 2009 pressrelease.htm
Exhibit 99.1
 

Press Release
For Further Information Contact:

INVESTORS:
MEDIA:
Frank Vitrano
Karen Rugen
(717) 972-3948
(717) 730-7766
or investor@riteaid.com
 

FOR IMMEDIATE RELEASE

 RITE AID REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2009 RESULTS

·
Fourth Quarter Net Loss of $2.67 per Diluted Share and Full Year Net Loss of $3.49 per Diluted Share Including Significant Non-Cash Charges Resulting from Impairment and Deferred Tax Asset Write Down
   
·
Fourth Quarter Net Loss of $0.14 per Diluted Share and Full Year Net Loss of $0.79 per Diluted Share Excluding the Impact of the Non-Cash Charges
   
·
Fourth Quarter Adjusted EBITDA of $261.4 Million and Full Year Adjusted EBITDA of $965.1 Million
   
·
Achieves Fourth Quarter Net Cash Provided by Operations of $324.8 Million
 
 
·
Liquidity Increased to $723.7 Million at Fiscal Year End
   
·
Management Focused on Operating Efficiency, Cutting Costs and Reducing Debt


CAMP HILL, PA (April 2, 2009)—Rite Aid Corporation (NYSE: RAD) today reported financial results for the fourth quarter and year ended February 28, 2009.

For the fourth quarter, the company reported revenues of $6.7 billion, a net loss of $2.3 billion or $2.67 per diluted share and adjusted EBITDA of $261.4 million.

Net loss for the quarter was impacted by significant non-cash charges resulting from goodwill impairment, store impairment and an additional tax valuation allowance against deferred tax assets.  These non-cash charges have no impact on the company’s business operations, liquidity, credit facilities or compliance with existing debt covenants.  Excluding these non-cash charges, net loss for the fourth quarter was $116.9 million or $0.14 per diluted share.


-MORE-

 
 

 

 
Rite Aid FY’09 Q4 Press Release – page 2

The one-time non-cash goodwill impairment charge accounted for $1.81 billion or $2.10 per diluted share of the fourth quarter net loss.  Similar to the recent experiences of other companies, Rite Aid was required by generally accepted accounting principles (GAAP, SFAS No. 142) to take a goodwill impairment charge, which is primarily the result of the company’s sustained low stock price and resulting market capitalization.  The company wrote off all of its goodwill, of which approximately $1.2 billion is related to the Brooks Eckerd acquisition.

Adjusted EBITDA (which is reconciled to net loss on the attached table) of $261.4 million or 3.9 percent of revenues for the fourth quarter compared to $276.3 million or 4.1 percent of revenues for the like period last year.  The $14.9 million decline was caused by higher union health and welfare contributions, higher occupancy costs as a result of sale leaseback transactions and higher accounts receivable securitization costs.

Fourth Quarter Highlights

·
Core Rite Aid pharmacy same store sales increases were strong in the fourth quarter and throughout the year, especially in light of the industrywide downturn in prescription sales and the increase in the company’s dispensing of generic prescriptions, which negatively impacts sales but improves margin.
·
Pharmacy same store sales trends in the acquired stores improved every quarter in fiscal 2009, narrowing to a decline of 1.9 percent in the fourth quarter compared to a 2.6 percent decline in the third quarter.
·
The company generated positive cash flow from operations of $324.8 million in the fourth quarter.
·
Significant progress in reducing selling, general and administration (SG&A) costs continued in the fourth quarter.
·
FIFO inventory was $243.6 million lower in the fourth quarter compared to last year and $379.3 million lower than the third quarter of this year.
·
The company maintained access to accounts receivable financing with renewal and completion of first and second lien securitization facilities.
·
Net cash from operations, including inventory reduction, and reduced capital expenditures contributed to availability of $723.7 million under the company’s revolving credit facility at year end.

“Despite continued weakness in the economy, we were able to improve our business significantly in the second half of the year as we completed the integration of Brooks Eckerd, enhanced our management team and focused on strengthening our financial position.  We made good progress operating our stores more efficiently, taking costs out of the business and reducing working capital, especially in the fourth quarter.  As a result, we ended the year with our strongest liquidity position in more than a year,” said Mary Sammons, Rite Aid chairman and CEO.

Commenting on the goodwill impairment, Sammons said, “This is a charge dictated by accounting rules.  We believe the impairment related to the Brooks Eckerd acquisition is not a true reflection of the long-term benefit we expect to see from our acquired stores.”

Fourth Quarter Summary

Revenues for the 13-week fourth quarter were $6.7 billion versus revenues of $6.8 billion in the prior year fourth quarter. Revenues decreased 1.7 percent, primarily as a result of 158 fewer stores this quarter as compared to the previous fourth quarter.
 
 
-MORE-
 

 
 

 

 
Rite Aid FY’09 Q4 Press Release – page 3

Same store sales for the quarter decreased 0.1 percent over the prior year 13-week period, consisting of a 2.0 percent decrease in the front end and a 0.8 percent increase in the pharmacy. Pharmacy sales included an approximate 301 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores decreased 0.9 percent, negatively impacted by the acquired stores.  The number of prescriptions filled increased in core Rite Aid stores.  Prescription sales accounted for 66.6 percent of total drugstore sales, and third party prescription revenue was 96.3 percent of pharmacy sales.

Excluding the acquired Brooks Eckerd stores, same stores sales for the 13-week fourth quarter increased 0.8 percent over the prior-year period with front end same store sales decreasing 1.9 percent and pharmacy same store sales growing 2.4 percent.

At the Brooks Eckerd stores, same store sales for the 13-week fourth quarter decreased 1.9 percent over the prior-year period.  Front end same store sales decreased 2.1 percent in the fourth quarter and pharmacy same store sales decreased 1.9 percent.

The fourth quarter net loss of $2.3 billion or $2.67 per diluted share compares to last year’s fourth quarter net loss of $952.2 million or $1.20 per diluted share. Excluding non-cash charges, net loss for the fourth quarter was $116.9 million or $0.14 per diluted share. The significant non-cash charges include 1) a one-time non-cash charge of $1.81 billion or $2.10 per share for goodwill impairment, 2) a non-cash income tax charge of $280.7 million or $0.33 per share from the recording of additional valuation allowance against deferred tax assets and 3) a non-cash charge of $85.8 million or $0.10 per share related to store impairment.  These items accounted for $2.2 billion or $2.53 per diluted share of the net loss. The LIFO charge was $94.6 million or $0.11 per share.  Last year’s fourth quarter included a non-cash charge of $894.9 million or $1.12 per share to record a valuation allowance against deferred tax assets.

In the fourth quarter, the company opened 6 stores, relocated 10 stores, and closed 19 stores. Stores in operation at the end of the fourth quarter totaled 4,901.

Full Year Results

For the 52-week fiscal year ended February 28, 2009, Rite Aid had revenues of $26.3 billion as compared to revenues of $24.3 billion for the 52-week prior year.  Revenues increased 8.1%, primarily driven by an additional quarter of sales for the Brooks Eckerd stores, which the company acquired on June 4, 2007.

Same store sales for the year, which include 39 weeks of the acquired stores, increased 0.8 percent over the prior 52-week comparable period. This increase consisted of a 0.9 percent front-end same store sales increase and a 0.7 percent increase in pharmacy same store sales.  The number of prescriptions filled in same stores decreased  0.96 percent, negatively impacted primarily by the acquired stores. Prescription revenue accounted for 67.2 percent of total sales, and third party prescription revenue was 96.3 percent of pharmacy sales.

Net loss for fiscal 2009 was $2.9 billion or $3.49 per diluted share compared to last year’s net loss of $1.1 billion or $1.54 per diluted share. Excluding significant non-cash charges, net loss for the year was $640 million or $0.79 per diluted share. The significant non-cash charges include 1) a non-cash charge of $1.81 billion for goodwill impairment, 2) a non-cash income tax charge of $307.7 million from the recording of additional valuation allowance against deferred tax assets and 3) a non-cash charge of $157.3 million related to store impairment.  These items accounted for $2.2 billion or $2.70 per diluted share of the net loss. The LIFO charge was $184.6 million or $0.22 per share.

-MORE-

 
 

 

 
Rite Aid FY’09 Q4 Press Release – page 4

As computed on the attached table, adjusted EBITDA of $965.1 million or 3.7 percent of revenues for the year compared to $962.8 million or 4.0 percent of revenues for last year.

For the year, the company opened 33 new stores, relocated 56 stores, remodeled 70 stores, acquired 9 stores, and sold or closed 200 stores. Stores in operation at the end of the year totaled 4,901.

Outlook for Fiscal 2010

The company said that in fiscal 2010 it will continue to focus on its initiatives to grow profitable sales, reduce operating expenses through additional efficiencies, improve working capital, take unnecessary costs out of the business and reduce capital expenditures.

“We are pleased with the results we have seen so far from these initiatives, and expect them to deliver greater benefits in fiscal 2010 and help us manage through this difficult operating environment,” Sammons said.  “We are focused on improving cash flows and expect to be in a position to start reducing our debt this year.”

Given the uncertainty of the retail environment, Rite Aid said it expects sales to be between $26.3 billion and $26.7 billion in fiscal 2010 with same store sales improving 0.5 to 2.5 percent over fiscal 2009.

Adjusted EBITDA (which is reconciled to net loss on the attached table) is expected to be between $1.025 billion and $1.125 billion. Accounts receivable securitization costs, which accounted for $26 million of adjusted EBITDA in fiscal 2009, will be excluded from adjusted EBITDA in fiscal 2010.

Net loss for fiscal 2010 is expected to be between $210 million and $435 million or a loss per diluted share of $.26 to $.53.  Capital expenditures are expected to be approximately $250 million.

Update On Proposed Reverse Stock Split

As previously announced, Rite Aid has delayed effecting the company’s proposed  reverse stock split following the New York Stock Exchange’s (NYSE) suspension of its minimum share price listing rule until June 30, 2009.  The suspension provides the company with additional time and flexibility to regain compliance with the rule.  Stockholders have approved a 1-for-10, 1-for-15 or 1-for-20 reverse stock split exchange ratio.

Per the rules of the suspension, Rite Aid can now regain compliance by achieving the required $1.00 closing share price and $1.00 average closing share price over the preceding 30 consecutive days on any of the following dates: April 16, 2009; April 30, 2009; May 29, 2009; June 30, 2009; and August 17, 2009.  Rite Aid’s Board of Directors will determine the exchange ratio and timing of the reverse stock split, if implemented, prior to or immediately following the end of the suspension period based on market conditions, the company’s share price and NYSE rules at such time.  Rite Aid continues to be listed and trade as usual on the NYSE.

Conference Call Broadcast

 Rite Aid will hold an analyst call at 8:30 a.m. Eastern Time today with remarks by Rite Aid's management team.  The call will be simulcast via the internet and can be accessed through the websites www.riteaid.com in the conference call section of investor information and www.StreetEvents.com.  Slides related to materials discussed on the call will be available on both sites.  A playback of the call will be available on both sites starting at 2 p.m. Eastern Time today.  A playback of the call will also be available by telephone for 48 hours beginning at 12 p.m. Eastern Time today until 12 p.m. Eastern Time on April 4.  The playback number is 1-800-642-1687 from within the U.S. and Canada or 1-706-645-9291 from outside the U.S. and Canada with the eight-digit reservation number 90511456.
 
-MORE-

 
 

 

 
Rite Aid FY’09 Q4 Press Release – page 5

Rite Aid Corporation is one of the nation’s leading drugstore chains with more than 4,900 stores in 31 states and the District of Columbia.  Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com.

This press release contains forward-looking statements, including guidance, which are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include our high level of indebtedness and our ability to refinance our indebtedness on terms favorable to us; our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements; our ability to improve the operating performance of our stores in accordance with our long term strategy, our ability to realize the benefits of the Brooks Eckerd acquisition, including positive same store sales growth for Brooks Eckerd and cost savings; our ability to hire and retain pharmacists and other store personnel; the efforts of private and public third-party payors to reduce prescription drug reimbursements and encourage mail order; competitive pricing pressures, including aggressive promotional activity from our competitors; our ability to manage expenses; our ability to realize the benefits from actions to further reduce costs and investment in working capital; continued consolidation of the drugstore industry; changes in state or federal legislation or regulations; the outcome of lawsuits and governmental investigations; the timing and effects of  our proposed reverse stock split; general economic conditions and inflation and  interest rate movements and  access to capital, including our continuing ability to complete sale and leaseback transactions. Consequently, all of the forward-looking statements made in this press release, including our guidance, are qualified by these and other factors, risks and uncertainties. Readers are also directed to consider other risks and uncertainties discussed in documents filed by the Company with the Securities and Exchange Commission. Forward-looking statements can be identified through the use of words such as "may", "will", "intend", "plan", "project", "expect", "anticipate", "could", "should", "would", "believe", "estimate", "contemplate", and "possible".

See the attached table for a reconciliation of a non-GAAP financial measure, Adjusted EBITDA to net income (loss), the most comparable GAAP financial measure. We define Adjusted EBITDA as net income (loss) from operations excluding the impact of income taxes, interest expense, depreciation and amortization, LIFO adjustments, charges or credits for store closing and impairment, inventory write-downs related to closed stores, stock-based compensation expense, debt modifications and retirements, sale of assets and investment, securitization costs (for fiscal 2010) and other non-recurring items. We reference this non-GAAP financial measure frequently in our decision-making because it provides supplemental information that facilitates internal comparisons to the historical operating performance of prior periods and external comparisons to competitors’ historical operating performance. In addition, incentive compensation is based on Adjusted EBITDA and we base our forward-looking estimates on Adjusted EBITDA to facilitate quantification of planned business activities and enhance subsequent follow-up with comparisons of actual to planned Adjusted EBITDA. We include this non-GAAP financial measure in our earnings announcement in order to provide transparency to our investors and enable investors to better compare our operating performance with the operating performance of our competitors.


###

 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
(unaudited)
             
   
February 28, 2009
   
March 1, 2008
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 152,035     $ 155,762  
Accounts receivable, net
    526,742       665,971  
Inventories, net of LIFO reserve of $746,467 and $562,729
    3,509,494       3,936,827  
Prepaid expenses and other current assets
    176,661       163,334  
Total current assets
    4,364,932       4,921,894  
Property, plant and equipment, net
    2,587,356       2,873,009  
Goodwill
    -       1,783,372  
Other intangibles, net
    1,017,011       1,187,327  
Deferred tax assets
    -       384,163  
Other assets
    357,241       338,258  
Total assets
  $ 8,326,540     $ 11,488,023  
                 
LIABILITIES AND STOCKHOLDERS' (DEFICIT)/EQUITY
               
Current liabilities:
               
Current maturities of long-term debt and lease financing obligations
  $ 40,683     $ 185,609  
Accounts payable
    1,256,982       1,425,768  
Accrued salaries, wages and other current liabilities
    1,004,762       1,110,288  
Deferred tax liabilities
    -       76,374  
Total current liabilities
    2,302,427       2,798,039  
Long-term debt, less current maturities
    5,801,230       5,610,489  
Lease financing obligations, less current maturities
    169,796       189,426  
Other noncurrent liabilities
    1,252,739       1,178,884  
Total liabilities
    9,526,192       9,776,838  
                 
Commitments and contingencies
    -       -  
Stockholders' (deficit)/equity:
               
Preferred stock - Series G
    1       139,253  
Preferred stock - Series H
    143,498       135,202  
Preferred stock - Series I
    -       116,415  
Common stock
    886,113       830,209  
Additional paid-in capital
    4,265,211       4,047,499  
Accumulated deficit
    (6,452,696 )     (3,537,276 )
Accumulated other comprehensive loss
    (41,779 )     (20,117 )
Total stockholders' (deficit)/equity
    (1,199,652 )     1,711,185  
Total liabilities and stockholders' (deficit)/equity
  $ 8,326,540     $ 11,488,023  
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share amounts)
(unaudited)
             
             
   
Thirteen Weeks
ended February 28,
2009
   
Thirteen Weeks
ended March 1,
2008
 
Revenues
  $ 6,707,567     $ 6,824,822  
Costs and expenses:
               
Cost of goods sold
    4,983,847       4,936,493  
Selling, general and administrative expenses
    1,699,889       1,774,296  
Lease termination and impairment charges
    104,021       43,713  
Goodwill impairment charge
    1,810,223       -  
Interest expense
    114,207       127,315  
(Gain) loss on sale of assets, net
    (358 )     958  
                 
      8,711,829       6,882,775  
                 
Loss from continuing operations before income taxes
    (2,004,262 )     (57,953 )
Income tax expense
    289,396       894,910  
                 
Net loss from continuing operations
    (2,293,658 )     (952,863 )
                 
Income from discontinued operations
    -       683  
                 
Net loss
  $ (2,293,658 )   $ (952,180 )
                 
Basic and diluted loss per share:
               
                 
Numerator for loss per share:
               
Net loss
  $ (2,293,658 )   $ (952,180 )
Accretion of redeemable preferred stock
    (25 )     (25 )
Cumulative preferred stock dividends
    (4,687 )     (8,238 )
Loss attributable to common stockholders - basic and diluted
  $ (2,298,370 )   $ (960,443 )
                 
                 
                 
Basic and diluted weighted average shares
    861,647       797,335  
                 
Basic and diluted loss per share
  $ (2.67 )   $ (1.20 )
 
 

 
 
RITE AID CORPORATION AND SUBSIDIARIES
 
SUPPLEMENTAL OPERATING AND CASH FLOW  INFORMATION
(Dollars in thousands, except per share amounts)
(unaudited)
             
             
   
Thirteen Weeks
ended February 28,
2009
   
Thirteen Weeks
ended March 1,
2008
 
             
SUPPLEMENTAL OPERATING INFORMATION
           
             
Revenues
  $ 6,707,567     $ 6,824,822  
Cost of goods sold
    4,983,847       4,936,493  
Gross profit
    1,723,720       1,888,329  
LIFO charge/(credit)
    94,569       (25,259 )
FIFO gross profit
    1,818,289       1,863,070  
                 
Gross profit as a percentage of revenues
    25.70%       27.67%  
LIFO charge/(credit)  as a percentage of revenues
    1.41%       -0.37%  
FIFO gross profit as a percentage of revenues
    27.11%       27.30%  
                 
Selling, general and administrative expenses
    1,699,889       1,774,296  
Selling, general and administrative expenses as a percentage of revenues
    25.34%       25.99%  
                 
Cash interest expense
    106,245       120,681  
Non-cash interest expense
    7,962       6,634  
Total interest expense
    114,207       127,315  
                 
Securitization costs
    9,142       5,025  
                 
Adjusted EBITDA
    261,381       276,262  
Adjusted EBITDA as a percentage of revenues
    3.90%       4.05%  
                 
Net loss
    (2,293,658 )     (952,180 )
Net loss as a percentage of revenues
    -34.20%       -13.95%  
                 
SUPPLEMENTAL CASH FLOW INFORMATION
               
                 
Payments for property, plant and equipment
    59,397       209,098  
Intangible assets acquired
    5,035       12,109  
Total cash capital expenditures
    64,432       221,207  
Equipment received for noncash consideration
    -       3,121  
Equipment financed under capital leases
    304       5,310  
Gross capital expenditures
  $ 64,736     $ 229,638  
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share amounts)
(unaudited)
             
             
   
Fifty-two Weeks
ended February 28,
2009
   
Fifty-two Weeks
ended March 1,
 2008
 
Revenues
  $ 26,289,268     $ 24,326,846  
Costs and expenses:
               
Cost of goods sold
    19,253,616       17,689,272  
Selling, general and administrative expenses
    6,985,367       6,366,137  
Lease termination and impairment charges
    293,743       86,166  
Goodwill impairment charge
    1,810,223       -  
Interest expense
    477,627       449,596  
Loss on debt modifications and retirements, net
    39,905       12,900  
Loss (gain) on sale of assets, net
    11,581       (3,726 )
                 
      28,872,062       24,600,345  
                 
Loss from continuing operations before income taxes
    (2,582,794 )     (273,499 )
Income tax expense
    329,257       802,701  
                 
Net loss from continuing operations
    (2,912,051 )     (1,076,200 )
                 
Loss from discontinued operations
    (3,369 )     (2,790 )
                 
Net loss
  $ (2,915,420 )   $ (1,078,990 )
                 
Basic and diluted loss per share:
               
                 
Numerator for loss per share:
               
Net loss
  $ (2,915,420 )   $ (1,078,990 )
Accretion of redeemable preferred stock
    (102 )     (102 )
Cumulative preferred stock dividends
    (21,768 )     (32,533 )
Preferred stock beneficial conversion
    -       (556 )
Loss attributable to common stockholders - basic and diluted
  $ (2,937,290 )   $ (1,112,181 )
                 
                 
                 
Basic and diluted weighted average shares
    840,812       723,923  
                 
Basic and diluted loss per share
  $ (3.49 )   $ (1.54 )
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
SUPPLEMENTAL OPERATING AND CASH FLOW  INFORMATION
(Dollars in thousands, except per share amounts)
(unaudited)
             
             
   
Fifty-two Weeks
ended February 28,
2009
   
Fifty-two Weeks
ended March 1,
2008
 
             
SUPPLEMENTAL OPERATING INFORMATION
           
             
Revenues
  $ 26,289,268     $ 24,326,846  
Cost of goods sold
    19,253,616       17,689,272  
Gross profit
    7,035,652       6,637,574  
LIFO charge
    184,569       16,114  
FIFO gross profit
    7,220,221       6,653,688  
                 
Gross profit as a percentage of revenues
    26.76%       27.28%  
LIFO charge as a percentage of revenues
    0.70%       0.07%  
FIFO gross profit as a percentage of revenues
    27.46%       27.35%  
                 
Selling, general and administrative expenses
    6,985,367       6,366,137  
Selling, general and administrative expenses as a percentage of revenues
    26.57%       26.17%  
                 
Cash interest expense
    450,896       425,135  
Non-cash interest expense
    26,731       24,461  
Total interest expense
    477,627       449,596  
                 
Securitization costs
    26,064       22,314  
                 
Adjusted EBITDA
    965,083       962,829  
Adjusted EBITDA as a percentage of revenues
    3.67%       3.96%  
                 
Net loss
    (2,915,420 )     (1,078,990 )
Net loss as a percentage of revenues
    -11.09%       -4.44%  
                 
SUPPLEMENTAL CASH FLOW INFORMATION
               
                 
Payments for property, plant and equipment
    460,857       687,529  
Intangible assets acquired
    80,489       52,846  
Total cash capital expenditures
    541,346       740,375  
Equipment received for noncash consideration
    23,878       3,411  
Equipment financed under capital leases
    8,117       11,667  
Gross capital expenditures
  $ 573,341     $ 755,453  
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(In thousands)
             
             
   
Thirteen Weeks
ended February 28,
2009
   
Thirteen Weeks
ended March 1,
2008
 
             
             
Reconciliation of net loss to adjusted EBITDA:
           
Net loss
  $ (2,293,658 )   $ (952,180 )
Adjustments:
               
Interest expense
    114,207       127,315  
Income tax expense
    289,396       895,278  
Depreciation and amortization
    144,859       134,532  
LIFO charges (credits) (a)
    94,569       (25,259 )
Lease termination and impairment charges (b)
    104,021       43,713  
Goodwill impairment charge (c)
    1,810,223       -  
Stock-based compensation expense
    5,527       12,821  
Gain on sale of assets, net
    (358 )     (7,142 )
Incremental acquisition costs (d)
    206       37,658  
Closed store liquidation expense (e)
    5,043       7,100  
Severance costs
    3,164       -  
Other (f)
    (15,818 )     2,426  
Adjusted EBITDA
  $ 261,381     $ 276,262  
Percent of revenues
    3.90%       4.05%  
                 
                 
Results of discontinued operations (g)
    -       4,325  
Adjusted EBITDA from continuing operations
  $ 261,381     $ 280,587  
 
Notes:
   
       
 
(a)
 
Represents non-cash charges (credits) to value our inventories under the last-in first-out ("LIFO") method.
       
 
(b)
 
Includes store impairment charges of $85,839 and $22,672 in the thirteen weeks ended February 28, 2009 and March 1, 2008, respectively.
       
 
(c)
 
Represents the total write-off of the Company's goodwill due to sustained low stock price and reduced market capitalization.
     
 
 
(d)
 
Represents incremental costs related to the acquisition of Jean Coutu, USA.
       
 
(e)
 
Represents costs to liquidate inventory at stores that are in the process of closing.
       
 
(f)
 
Other for the thirteen week period ended February 28, 2009 includes a non-recurring litigation settlement, partially offset by fees incurred to complete our second lien receivables facility.
       
 
(g)
 
Represents losses from our disposed Las Vegas market that are included in prior year's Adjusted EBITDA.
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(In thousands)
             
             
   
Fifty-two Weeks
ended February 28,
2009
   
Fifty-two Weeks
ended March 1,
2008
 
             
             
Reconciliation of net loss to adjusted EBITDA:
           
Net loss
  $ (2,915,420 )   $ (1,078,990 )
Adjustments:
               
Interest expense
    477,627       449,596  
Income tax expense
    329,257       801,198  
Depreciation and amortization
    586,208       472,473  
LIFO charges (a)
    184,569       16,114  
Lease termination and impairment charges (b)
    293,743       86,166  
Goodwill impairment charge (c)
    1,810,223       -  
Stock-based compensation expense
    31,448       40,439  
Loss (gain) on sale of assets, net
    11,629       (11,826 )
Loss on debt modifications and retirements, net (d)
    39,905       12,900  
Incremental acquisition costs (e)
    85,633       154,222  
Closed store liquidation expense (f)
    19,353       14,396  
Severance costs
    13,653       -  
Other
    (2,745 )     6,141  
Adjusted EBITDA
  $ 965,083     $ 962,829  
Percent of revenues
    3.67%       3.96%  
                 
                 
Results of discontinued operations (g)
    1,882       8,890  
Adjusted EBITDA from continuing operations
  $ 966,965     $ 971,719  
 
Notes:
   
       
 
(a)
 
Represents non-cash charges to value our inventories under the last-in first-out ("LIFO") method.
       
 
(b)
 
Includes store impairment charges of $157,335 and $30,822 in the 52 weeks ended February 28, 2009 and March 1, 2008, respectively.
       
 
(c)
 
Represents the total write-off of the Company's goodwill due to sustained low stock price and reduced market capitalization.
       
 
(d)
 
Represents loss related to debt modifications and retirements, net.
       
 
(e)
 
Represents incremental costs related to the acquisition of Jean Coutu, USA.
       
 
(f)
 
Represents costs to liquidate inventory at stores that are in the process of closing.
       
 
(g)
 
Represents losses from our disposed Las Vegas market that are included in prior year's Adjusted EBITDA.
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Dollars in thousands)
 
(unaudited)
 
             
             
             
   
Thirteen Weeks
ended February 28,
2009
   
Thirteen Weeks
ended March 1,
2008
 
             
             
 OPERATING ACTIVITIES:
           
 Net loss
  $ (2,293,658 )   $ (952,180 )
 Adjustments to reconcile to net cash provided by operating activities:
               
 Depreciation and amortization
    144,859       134,532  
 Lease termination and impairment charges
    104,021       43,713  
 Goodwill impairment charge
    1,810,223       -  
 LIFO charges (credits)
    94,569       (25,259 )
 Gain on sale of assets, net
    (358 )     (7,142 )
 Stock-based compensation expense
    5,527       12,821  
 Changes in deferred taxes
    280,734       895,076  
 Proceeds from sale of inventory
    -       8,655  
 Changes in operating assets and liabilities:
               
 Net (repayments to) proceeds from accounts receivable securitization
    (5,119 )     35,000  
 Accounts receivable
    70,700       28,776  
 Inventories
    378,555       254,784  
 Accounts payable
    (87,994 )     (75,787 )
 Other assets and liabilities, net
    (177,281 )     (43,546 )
 Net cash provided by operating activities
    324,778       309,443  
 INVESTING ACTIVITIES:
               
 Payments for property, plant and equipment
    (59,397 )     (209,098 )
 Intangible assets acquired
    (5,035 )     (12,109 )
 Expenditures for business acquisition
    -       (220 )
 Proceeds from sale-leaseback transactions
    -       28,228  
 Proceeds from dispositions of assets and investments
    10,643       34,904  
 Net cash used in investing activities
    (53,789 )     (158,295 )
 FINANCING ACTIVITIES:
               
 Proceeds from issuance of long-term debt
    -       1,862  
 Net payments to revolver
    (308,000 )     (159,000 )
 Principal payments on long-term debt
    (7,892 )     (5,020 )
 Proceeds from financing secured by owned property
    -       44,267  
 Change in zero balance cash accounts
    48,078       (41,452 )
 Net proceeds from the issuance of common stock
    -       42  
 Payments for preferred stock dividends
    -       (3,845 )
 Excess tax deduction on stock options
    -       (5,882 )
 Net cash used in financing activities
    (267,814 )     (169,028 )
 Increase (decrease) in cash and cash equivalents
    3,175       (17,880 )
 Cash and cash equivalents, beginning of period
    148,860       173,642  
 Cash and cash equivalents, end of period
  $ 152,035     $ 155,762  
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Dollars in thousands)
 
(unaudited)
 
             
             
             
   
Fifty-two Weeks
ended February 28,
2009
   
Fifty-two Weeks
ended March 1,
2008
 
             
             
 OPERATING ACTIVITIES:
           
 Net loss
  $ (2,915,420 )   $ (1,078,990 )
 Adjustments to reconcile to net cash provided by operating activities:
               
 Depreciation and amortization
    586,208       472,473  
 Lease termination and impairment charges
    293,743       86,166  
 Goodwill impairment charge
    1,810,223       -  
 LIFO charges
    184,569       16,114  
 Loss (gain) on sale of assets, net
    11,629       (11,826 )
 Stock-based compensation expense
    31,448       40,439  
 Loss on debt modifications and retirements, net
    39,905       12,900  
 Changes in deferred taxes
    307,789       805,204  
 Proceeds from sale of inventory
    -       16,811  
 Proceeds from insured loss
    -       8,550  
 Changes in operating assets and liabilities:
               
 Net proceeds from accounts receivable securitization
    104,881       85,000  
 Accounts receivable
    33,784       36,820  
 Inventories
    196,517       (306,360 )
 Accounts payable
    (140,258 )     (115,624 )
 Other assets and liabilities, net
    (185,108 )     11,691  
 Net cash provided by operating activities
    359,910       79,368  
 INVESTING ACTIVITIES:
               
 Payments for property, plant and equipment
    (460,857 )     (687,529 )
 Intangible assets acquired
    (80,489 )     (52,846 )
 Expenditures for business acquisition
    (112 )     (2,306,774 )
 Proceeds from sale-leaseback transactions
    161,553       48,985  
 Proceeds from dispositions of assets and investments
    33,547       58,470  
 Proceeds from insured loss
    -       5,950  
 Net cash used in investing activities
    (346,358 )     (2,933,744 )
 FINANCING ACTIVITIES:
               
 Proceeds from issuance of long-term debt
    900,629       2,307,867  
 Net (payments to) proceeds from revolver
    (11,000 )     549,000  
 Proceeds from financing secured by owned property
    31,266       44,267  
 Principal payments on long-term debt
    (870,054 )     (15,939 )
 Change in zero balance cash accounts
    (16,298 )     79,606  
 Net proceeds from the issuance of common stock
    1,117       12,764  
 Payments for preferred stock dividends
    (3,466 )     (15,380 )
 Financing costs paid
    (49,473 )     (58,195 )
 Net cash (used in) provided by financing activities
    (17,279 )     2,903,990  
 (Decrease) increase in cash and cash equivalents
    (3,727 )     49,614  
 Cash and cash equivalents, beginning of period
    155,762       106,148  
 Cash and cash equivalents, end of period
  $ 152,035     $ 155,762  
 
 

 
RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS GUIDANCE TO ADJUSTED EBITDA GUIDANCE
YEAR ENDING FEBRUARY 27, 2010
(In thousands, except per share amounts)
 
 
   
Guidance Range
 
   
Low
   
High
 
             
Sales
  $ 26,300,000     $ 26,700,000  
                 
Same store sales
    0.50%       2.50%  
                 
Gross capital expenditures
  $ 250,000     $ 250,000  
                 
Reconciliation of net loss to adjusted EBITDA:
               
Net loss
  $ (435,000 )   $ (210,000 )
Adjustments:
               
Interest expense and securitization costs (a)
    530,000       515,000  
Income tax expense
    17,000       16,000  
Depreciation and amortization
    565,000       545,000  
LIFO charge
    70,000       50,000  
Store closing, liquidation, and impairment charges
    242,000       204,000  
Stock-based compensation expense
    25,000       20,000  
Other
    11,000       (15,000 )
Adjusted EBITDA (a)
  $ 1,025,000     $ 1,125,000  
                 
                 
Diluted loss per share
  $ (0.53 )   $ (0.26 )
   
   
 
(a)
Adjusted EBITDA of $965,083 for the year ended February 28, 2009 included securitization costs of $26,064.